These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1397812)

  • 21. Proposed guidelines for housestaff interaction with pharmaceutical companies.
    Forrest DM; Ruedy J
    Ann R Coll Physicians Surg Can; 1993 Oct; 26(5):291-3. PubMed ID: 15362243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmaceutical policies in Canadian family medicine training. Survey of residency programs.
    Mahood S; Zagozeski C; Bradel T; Lawrence K
    Can Fam Physician; 1997 Nov; 43():1947-51. PubMed ID: 9386881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structured pharmaceutical representative interactions and counterdetailing sessions as components of medical resident education.
    Wall GC; Smith HL; Craig SR; Yost WJ
    J Pharm Pract; 2013 Apr; 26(2):151-6. PubMed ID: 23340914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmaceutical industry interactions in family medicine residencies decreased between 2008 and 2013: a CERA study.
    Brown SR; Evans DV; Fugh-Berman A
    Fam Med; 2015 Apr; 47(4):279-82. PubMed ID: 25853598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the pharmaceutical industry in teaching psychopharmacology: a growing problem.
    Brodkey AC
    Acad Psychiatry; 2005; 29(2):222-9. PubMed ID: 15937271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The changing relationship between health care professionals and the pharmaceutical industry.
    Arriola E
    Hosp Formul; 1995 Mar; 30(3):161-5; discussion 163-9. PubMed ID: 10141248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of an industry relations policy by the association of program directors in surgery: a report from the finance committee.
    Termuhlen PM; Damewood RB; Dent D; Fuhrman G; Haisch C; Nelson MT; Borman K; Friedell M;
    J Surg Educ; 2011; 68(5):347-9. PubMed ID: 21821210
    [No Abstract]   [Full Text] [Related]  

  • 28. Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario.
    Sergeant MD; Hodgetts PG; Godwin M; Walker DM; McHenry P
    CMAJ; 1996 Nov; 155(9):1243-8. PubMed ID: 8911290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physicians and the pharmaceutical industry (update 2001).
    Canadian Medical Association
    CMAJ; 2001 May; 164(9):1339-44. PubMed ID: 11341156
    [No Abstract]   [Full Text] [Related]  

  • 30. AAFP Congress approves statement on ethics of proprietary relationships.
    Am Fam Physician; 1991 Dec; 44(6):2233-9. PubMed ID: 1746398
    [No Abstract]   [Full Text] [Related]  

  • 31. Structured approach to pharmaceutical representatives. Family medicine residency program.
    Kelcher S; Brownoff R; Meadows LM
    Can Fam Physician; 1998 May; 44():1053-6, 1059-60. PubMed ID: 9612591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethics and industry-sponsored research.
    Pater JL; Parulekar W; O'Callagham C; Shepherd L; Eisenhouer E; Seymour L; Tu D; Ding K
    CMAJ; 2002 Mar; 166(5):581-2. PubMed ID: 11898934
    [No Abstract]   [Full Text] [Related]  

  • 33. Proposed model for interaction between residents and residency training programs, and pharmaceutical industry.
    Razack S; Arbour L; Hutcheon R
    Ann R Coll Physicians Surg Can; 1999 Mar; 32(2):93-6. PubMed ID: 12378718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Academic medicine and the pharmaceutical industry: a cautionary tale.
    Guyatt G
    CMAJ; 1994 Mar; 150(6):951-3. PubMed ID: 8131127
    [No Abstract]   [Full Text] [Related]  

  • 35. Addressing the pharmaceutical industry's influence on professional behaviour.
    Woollard RF
    CMAJ; 1993 Aug; 149(4):403-4. PubMed ID: 8348421
    [No Abstract]   [Full Text] [Related]  

  • 36. Statement on surgical residencies and the educational environment. American College of Surgeons, Graduate Medical Education Committee.
    Bull Am Coll Surg; 1994 Jan; 79(1):89-93. PubMed ID: 10131430
    [No Abstract]   [Full Text] [Related]  

  • 37. Guidelines and policies for medical writers in the biotech industry: an update on the controversy.
    Foote M
    Biotechnol Annu Rev; 2004; 10():259-64. PubMed ID: 15504710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring systems-based practice in a sample of physical medicine and rehabilitation residency programs.
    Elwood D; Kirschner JS; Moroz A; Berliner J
    PM R; 2009 Mar; 1(3):223-8. PubMed ID: 19627898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. There is no such thing as a free lunch. Developing policies on pharmaceutical industry support.
    Newton W; Goldstein A; Frey J
    J Fam Pract; 1992 Jan; 34(1):32-4. PubMed ID: 1728651
    [No Abstract]   [Full Text] [Related]  

  • 40. [Residents and pharmaceutical industry].
    Chabot JM
    Rev Prat; 2004 Apr; 54(8):875-6. PubMed ID: 15274462
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.